Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
about
Hallmarks of cancer and AU-rich elementsSTAT3 oligonucleotide inhibits tumor angiogenesis in preclinical models of squamous cell carcinomaControl by a hair's breadth: the role of microRNAs in the skinHCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell linesCharacterization of squamous cell carcinoma in an organotypic culture via subsurface non-linear optical molecular imaging.The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy.TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer.Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer.Concise review: custodians of the transcriptome: how microRNAs guard stemness in squamous epithelia.CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolinThe Proton-Sensing G-Protein Coupled Receptor GPR4 Promotes Angiogenesis in Head and Neck CancerAcupuncture for dysphagia after chemoradiation in head and neck cancer: rationale and design of a randomized, sham-controlled trial.Control of cytokine mRNA expression by RNA-binding proteins and microRNAs.Expression of NF-κB and IL-6 in oral precancerous and cancerous lesions: An immunohistochemical studyInactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6.Health behaviors predict higher interleukin-6 levels among patients newly diagnosed with head and neck squamous cell carcinomamiR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory diseaseCisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.Tristetraprolin: roles in cancer and senescence.Interleukin-6 as a therapy target in oral squamous carcinoma.Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.Post-transcriptional regulation of cytokine and growth factor signaling in cancer.Salivary and Serum Interleukin-6 Levels in Oral Premalignant Disorders and Squamous Cell Carcinoma: Diagnostic Value and Clinicopathologic CorrelationsRNA binding proteins regulate anabolic and catabolic gene expression in chondrocytes.Gain-of-Function Mutation of Tristetraprolin Impairs Negative Feedback Control of Macrophages In Vitro yet Has Overwhelmingly Anti-Inflammatory Consequences In Vivo.Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3' untranslated region.Mathematical Modeling of Cellular Cross-Talk Between Endothelial and Tumor Cells Highlights Counterintuitive Effects of VEGF-Targeted Therapies.Endonuclease Regnase-1/Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) in controlling immune responses and beyond.Expression of the mRNA stability regulator Tristetraprolin is required for lactation maintenance in the mouse mammary gland.
P2860
Q26744134-85ECF86F-35DD-4B63-AAB9-173DD43C6DFDQ28538302-2143EAFE-C181-4656-A3E3-7B2F75C5C30EQ28709944-4E0BFA84-091B-4C0E-BD29-96D5822E1D49Q30278790-AE69E451-5849-4A4D-9441-6292B37ADC42Q30596710-41E739A5-7918-49FE-99B6-AD150A0D3D0BQ33623170-5D089F8D-9D83-49B5-B215-A0D75C117600Q34200816-3CB6831B-6D38-4FFC-B0FE-2E3318E8E1EDQ34248613-FF3675A8-10CE-4267-A2BE-F87E8E58A9EFQ34644985-4776798F-7539-4BF0-BBD5-BDEBDA82696CQ34902060-9A1419AD-4222-4B91-BE81-EEC73CEFC63BQ35359747-D330ED80-7C49-4EAB-8839-4B39D8DCFBE3Q35534230-D18AE2D7-8E08-498F-8009-9E176250D3C7Q35989833-E32D4622-0F1F-49C7-9774-30A7638BF1CDQ36029237-611EE896-99A9-4139-88BD-2544A0E15118Q36060384-CD87979D-52FF-4302-A842-F88CEC1ADA8BQ36613784-F378A31E-46B9-405D-BCA1-F579C4D5574CQ36675764-05F559D1-BC03-4570-8056-FBA328521BEEQ36681030-B4FD288A-88C5-4A99-9DCB-1CF5ACEDB5C2Q37066933-DF8E9BC8-2DE5-4CA2-9BF2-777FFF01D66EQ37119721-8F06A237-9EC3-4C17-9EA8-9855C89D0D1FQ37125741-087EB0C9-3110-43B8-9314-B81C1004C4F0Q37689601-DE8AB268-37C2-47CA-AC63-4906076231EEQ37990333-1CF77F95-3B37-49C8-A8D8-944120B7F79BQ38055760-CA9D7457-B212-425D-B474-6FBC02FCE998Q38778534-192AAD6C-0AA3-42A7-91BC-EEB2E8CF42B5Q39036700-C03EADF5-0B4F-4D37-A0FE-787360684FD4Q39054602-0902CE3B-4401-431B-A349-A14709F5A174Q41977523-618559C0-B81A-4E94-8DDE-A00B5229ED5EQ42251092-AE1CFF6A-F643-4A31-83A5-19F69F08008DQ42279904-8E46EEB8-DC72-4BCE-844A-1984123720F9Q47325265-3504DAA4-31E2-4B42-BE23-6D590DFD0A70Q47773805-8916768C-58E2-4848-874D-A5E0CA0AFC03Q50316899-F38814A9-8627-4D37-AB02-81F251C060EA
P2860
Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tristetraprolin regulates inte ...... neck squamous cell carcinoma.
@ast
Tristetraprolin regulates inte ...... neck squamous cell carcinoma.
@en
type
label
Tristetraprolin regulates inte ...... neck squamous cell carcinoma.
@ast
Tristetraprolin regulates inte ...... neck squamous cell carcinoma.
@en
prefLabel
Tristetraprolin regulates inte ...... neck squamous cell carcinoma.
@ast
Tristetraprolin regulates inte ...... neck squamous cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Tristetraprolin regulates inte ...... neck squamous cell carcinoma.
@en
P2093
Carol Bradford
Elizabeth Van Tubergen
Gregory Wolf
Keith L Kirkwood
Mark Prince
Nisha J D'Silva
Robert Vander Broek
Thomas Carey
P2860
P304
P356
10.1002/CNCR.25859
P407
P577
2011-01-10T00:00:00Z